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The prevalence of congenital heart disease (CHD) is approximately 8 cases per 1,000 live 
births. Paediatric care for patients with congenital heart disease, over the past 25 years, has 
been so outstanding that as many as 85% of these children now survive into adulthood. Given 
these successes, there is a “new group of patients”.The number of adults with congenital heart 
disease is likely to exceed paediatric patients with CHD by 2020.
About 55% of adults suffering from ACHD are considered to be at medium or high risk for 
complications, re-operations, premature / sudden cardiac deaths or arrhythmias . ACHD is 
also the major cause of morbidity and mortality from heart disease in pregnancy and 20% of 
deaths are potentially avoidable.
The majority of congenital heart disease patients are in the age group 30-40 and are otherwise 
economically active. This number will increase with time due to improvements in health care 
technology, better operative surgical techniques and neonatal care; allowing more of these 
individuals to  survive to adulthood. Currently, these patients are being cared for by paediatric 
doctors or adult cardiologists who may not be well equipped to deal with the complex problems 
like pregnancy, arrhythmias , pulmonary hypertension and coronary artery disease, thus a 
need for new strategies  of care. This includes multidisciplinary teams equipped with skill sets 
for exericse testing, psychosocial support , imageing , electrophysiological testing , pulmonary 
hypertension and preganancy support.  Continued education of patients with ACHD , use of 
medical passports , use of information technology to track high risk patients are all crucial 
pieces to ensure that patients have the highest quality of life and optimal functioning in their 
later years.
